Xaira Therapeutics
Healthcare AI
AI drug discovery and development
Seed
Xaira Therapeutics is an integrated biotechnology company using artificial intelligence to reengineer drug discovery and development end to end, combining machine learning research, large-scale data generation, and therapeutic product development to create new medicines. The company says it is building predictive and agentic AI models across the drug discovery and development process and has sites in South San Francisco, Seattle, and London.
Company Details
- Website
- xaira.com
- Headquarters
- South San Francisco, California, United States
- Founded
- 2023
- Funding
- $1B
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring